AN2 Therapeutics Market Sentiment

SPY757.12+0.19%QQQ692.74+0.33%BTC/USD77,282.87+0.13%DIA517.65+0.10%GLD356.15+0.10%TLT81.65−0.23%

Premium Services

AN2 Therapeutics Inc

ANTXNASDAQ

Trade with Public

$4.53

-0.16-3.41%

Last update: Oct 30, 4:00 PM

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Stock Report

AN2 Therapeutics Market Sentiment

Market sentiment signals for AN2 Therapeutics (ANTX): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Market Outperform

Short Interest▼ 9.1% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Market Outperform

7 analysts

Options Flow (P/C)

—

Avg Consensus PT

+19.2%

Highest Price Target

+98.7%

Leerink Partners

Lowest Price Target

-55.8%

JMP Securities

Short Interest

9.1%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Jul 20, 2026	Guggenheim	Brad Canino—	+98.7%	$9	Initiate	Buy
May 14, 2026	Leerink Partners	Joseph Schwartz—	+98.7%	$9	Upgrade	Market Perform→Outperform
May 5, 2025	JMP Securities	Roy Buchanan—	-55.8%	$5 → $2	Maintained	Market Outperform
Mar 26, 2025	Citizens Capital Markets	Roy Buchanan—	+10.4%	$5 → $5	Maintained	Market Outperform
Feb 25, 2025	Citizens Capital Markets	Roy Buchanan—	+10.4%	$5 → $5	Maintained	Market Outperform
Feb 3, 2025	JMP Securities	Roy Buchanan—	+10.4%	$5 → $5	Maintained	Market Outperform
Nov 19, 2024	JMP Securities	Roy Buchanan—	+10.4%	$5 → $5	Maintained	Market Outperform
Nov 18, 2024	TD Cowen	Ritu Baral—	—	—	Downgrade	Buy→Hold
Aug 9, 2024	JMP Securities	Roy Buchanan—	-33.8%	$6 → $3	Maintained	Market Outperform
Jul 3, 2024	Leerink Partners	Joseph Schwartz—	—	—	Upgrade	Market Perform→Outperform
May 16, 2024	Evercore ISI Group	Liisa Bayko—	-55.8%	$7 → $2	Maintained	In-Line
Apr 2, 2024	JMP Securities	Roy Buchanan—	+32.5%	$6	Upgrade	Market Perform→Market Outperform
Apr 1, 2024	Oppenheimer	Jeff Jones—	—	—	Maintained	Perform
Feb 13, 2024	Leerink Partners	Joseph Schwartz—	+54.5%	$23 → $7	Downgrade	Outperform→Market Perform
Feb 12, 2024	Evercore ISI Group	Liisa Bayko—	+54.5%	$25 → $7	Downgrade	Outperform→In-Line
Feb 12, 2024	Oppenheimer	Jeff Jones—	—	—	Downgrade	Outperform→Perform
Feb 12, 2024	JMP Securities	Roy Buchanan—	—	—	Downgrade	Market Outperform→Market Perform
Jan 4, 2024	JMP Securities	Roy Buchanan—	+562.3%	$30	Initiate	Market Outperform